BOA1

Featured post

#Update: Increase in #Human #Infections with #Avian #Influenza #H7N9 Viruses During the 5th #Epidemic — #China, Oct. ‘16–Aug. 7 ‘17 (@CDCgov, edited)

Title : #Update: Increase in #Human #Infections with #Avian #Influenza #H7N9 Viruses During the 5th #Epidemic — #China, Oct. ‘16–Aug. 7 ‘17....

25 Jun 2017

#Influenza and other #Respiratory #Viruses #Research #References #Library– June 25 2017 Issue


Title: #Influenza and other #Respiratory #Viruses #Research #References #Library– June 25 2017 Issue.

Subject:  Animal and Human Influenza Viruses, other respiratory pathogens research, weekly references library update.

Source: AMEDEO, homepage: (LINK).

Code: [  R  ]

_____

New References:

___

  1. PAUL SS, Mok CK, Mak TM, Ng OW, et al.
    • A cross-clade H5N1 influenza A virus neutralizing monoclonal antibody binds to a novel epitope within the vestigial esterase domain of hemagglutinin.
      • Antiviral Res. 2017 Jun 17. pii: S0166-3542(17)30042.
  2. LIU M, Lo EC, Wang G, Chow HF, et al.
    • Identification of influenza polymerase inhibitors targeting polymerase PB2 cap-binding domain through virtual screening.
      • Antiviral Res. 2017 Jun 16. pii: S0166-3542(16)30584.
  3. MOATASIM Y, Kandeil A, Mostafa A, Elghaffar SKA, et al.
    • Single gene reassortment of highly pathogenic avian influenza A H5N1 in the low pathogenic H9N2 backbone and its impact on pathogenicity and infectivity of novel reassortant viruses.
      • Arch Virol. 2017 Jun 15. doi: 10.1007/s00705-017-3434.
  4. MORBEY RA, Harcourt S, Pebody R, Zambon M, et al.
    • The burden of seasonal respiratory infections on a national telehealth service in England.
      • Epidemiol Infect. 2017;145:1922-1932.
  5. KESAVARDHANA S, Kuriakose T, Guy CS, Samir P, et al.
    • ZBP1/DAI ubiquitination and sensing of influenza vRNPs activate programmed cell death.
      • J Exp Med. 2017 Jun 20. pii: jem.20170550. doi: 10.1084/jem.20170550.
  6. PASICK J, Diederich S, Berhane Y, Embury-Hyatt C, et al.
    • Imbalance between innate antiviral and pro-inflammatory immune responses may contribute to different outcomes involving low- and highly pathogenic avian influenza H5N3 infections in chickens.
      • J Gen Virol. 2017 Jun 21. doi: 10.1099/jgv.0.000801.
  7. DUCATEZ M, Sonnberg S, Crumpton JC, Rubrum A, et al.
    • Highly pathogenic avian influenza H5N1 clade 2.3.2.1 and clade 2.3.4 viruses do not induce a clade-specific phenotype in mallard ducks.
      • J Gen Virol. 2017 Jun 20. doi: 10.1099/jgv.0.000806.
  8. WONG CK, Smith CA, Sakamoto K, Kaminski N, et al.
    • Aging Impairs Alveolar Macrophage Phagocytosis and Increases Influenza-Induced Mortality in Mice.
      • J Immunol. 2017 Jun 23. pii: ji1700397. doi: 10.4049/jimmunol.1700397.
  9. WANG Y, Li T, Chen Y, Wei H, et al.
    • Involvement of NK Cells in IL-28B-Mediated Immunity against Influenza Virus Infection.
      • J Immunol. 2017 Jun 21. pii: ji1601430. doi: 10.4049/jimmunol.1601430.
  10. PAULES CI, Lakdawala S, McAuliffe JM, Paskel M, et al.
    • An HA stem antibody MEDI8852 prevents and controls disease and limits transmission of pandemic influenza viruses.
      • J Infect Dis. 2017 Jun 17. doi: 10.1093.
  11. CHUNG JR, Flannery B, Zimmerman RK, Nowalk MP, et al.
    • Prior season vaccination and risk of influenza during the 2014-2015 season in the U.S.
      • J Infect Dis. 2017 Jun 13. doi: 10.1093.
  12. PHIPPS KL, Marshall N, Tao H, Danzy S, et al.
    • Seasonal H3N2 and 2009 pandemic H1N1 influenza A viruses reassort efficiently but produce attenuated progeny.
      • J Virol. 2017 Jun 21. pii: JVI.00830-17. doi: 10.1128/JVI.00830.
  13. CLARK AM, Nogales A, Martinez-Sobrido L, Topham DJ, et al.
    • Functional evolution of influenza NS1 protein in currently circulating human 2009 pandemic H1N1 viruses.
      • J Virol. 2017 Jun 21. pii: JVI.00721-17. doi: 10.1128/JVI.00721.
  14. NOGALES A, Rodriguez L, DeDiego ML, Topham DJ, et al.
    • Interplay of PA-X and NS1 proteins in replication and pathogenesis of a temperature-sensitive 2009 pandemic H1N1 influenza A virus.
      • J Virol. 2017 Jun 21. pii: JVI.00720-17. doi: 10.1128/JVI.00720.
  15. MORRISON BJ, Roman JA, Luke TC, Nagabhushana N, et al.
    • Antibody-dependent NK cell degranulation as a marker for assessing antibody-dependent cytotoxicity against pandemic 2009 influenza A(H1N1) infection in human plasma and influenza-vaccinated transchromosomic bovine intravenous immunoglobulin therapy.
      • J Virol Methods. 2017;248:7-18.
  16. DUNKLE LM, Izikson R, Patriarca P, Goldenthal KL, et al.
    • Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older.
      • N Engl J Med. 2017;376:2427-2436.
  17. SIKORA D, Rocheleau L, Brown EG, Pelchat M, et al.
    • Influenza A virus cap-snatches host RNAs based on their abundance early after infection.
      • Virology. 2017;509:167-177.
  18. CHLANDA P.
    • Influenza Hemagglutinin and M2 ion channel priming by trypsin: Killing two birds with one stone.
      • Virology. 2017;509:131-132.
  19. PATEL H, Kukol A.
    • Evolutionary conservation of influenza A PB2 sequences reveals potential target sites for small molecule inhibitors.
      • Virology. 2017;509:112-120.
  20. SMITH GE, Sun X, Bai Y, Liu YV, et al.
    • Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.
      • Virology. 2017;509:90-97.
  21. DENG L, Kim JR, Chang TZ, Zhang H, et al.
    • Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge.
      • Virology. 2017;509:82-89.

-

Keywords: Research; Abstracts; Influenza References Library.

------